RORα and RORγ expression inversely correlates with human melanoma progression

被引:53
作者
Brozyna, Anna A. [1 ,2 ]
Jozwicki, Wojciech [1 ,2 ]
Skobowiat, Cezary [3 ]
Jetten, Anton [4 ]
Slominski, Andrzej T. [5 ,6 ,7 ]
机构
[1] Prof Franciszek Lukaszczyk Mem Hosp, Ctr Oncol, Dept Tumor Pathol & Pathomorphol, Bydgoszcz, Poland
[2] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Fac Hlth Sci, Dept Tumor Pathol & Pathomorphol, Bydgoszcz, Poland
[3] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Fac Pharm, Dept Pharmacodynam & Mol Pharmacol, Bydgoszcz, Poland
[4] NIEHS, Cell Biol Sect, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA
[5] Univ Alabama Birmingham, Dept Dermatol, Canc Chemoprevent Program, Birmingham, AL 35294 USA
[6] Univ Alabama Birmingham, Ctr Comprehens Canc, Canc Chemoprevent Program, Birmingham, AL 35294 USA
[7] VA Med Ctr, Pathol & Lab Med Serv, Birmingham, AL 35233 USA
基金
美国国家卫生研究院;
关键词
melanoma; ROR alpha; ROR gamma; melanocytic nevi; vitamin D; ORPHAN RECEPTORS RORS; GENE-EXPRESSION; REV-ERB; TRANSCRIPTIONAL REGULATION; CHOLESTEROL SULFATE; NUCLEAR RECEPTORS; L-TYROSINE; SKIN; DIFFERENTIATION; MELANOGENESIS;
D O I
10.18632/oncotarget.11211
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The retinoic acid-related orphan receptors (RORs) regulate several physiological and pathological processes, including immune functions, development and cancer. To study the potential role of RORs in melanoma progression, we analysed ROR alpha and ROR gamma expression in nevi and primary melanomas and non-lesional skin and metastases in relation to melanoma clinico-pathomorphological features. The expression of ROR alpha and ROR gamma was lower in melanomas than in nevi and decreased during melanoma progression, with lowest levels found in primary melanomas at stages III and IV and in melanoma metastases. Their expression correlated with pathomorphological pTNM parameters being low in aggressive tumors and being high in tumors showing histological markers of good prognosis. Higher nuclear levels of ROR alpha and ROR gamma and of cytoplasmic ROR gamma correlated with significantly longer overall and disease free survival time. Highly pigmented melanomas showed significantly lower level of nuclear RORs. This study shows that human melanoma development and aggressiveness is associated with decreased expression of ROR alpha and ROR gamma, suggesting that RORs could be important in melanoma progression and host responses against the tumor. Furthermore, it suggests that ROR alpha and ROR gamma might constitute a novel druggable target in anti-melanoma management using tumor suppressor gene therapy restoring their normal functions.
引用
收藏
页码:63261 / 63282
页数:22
相关论文
共 82 条
[21]   ROR-GAMMA - THE 3RD MEMBER OF ROR-RZR ORPHAN RECEPTOR SUBFAMILY THAT IS HIGHLY EXPRESSED IN SKELETAL-MUSCLE [J].
HIROSE, T ;
SMITH, RJ ;
JETTEN, AM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (03) :1976-1983
[22]   Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic [J].
Hoffman, RM .
INVESTIGATIONAL NEW DRUGS, 1999, 17 (04) :343-359
[23]   Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts [J].
Hoffman, Robert M. .
NATURE REVIEWS CANCER, 2015, 15 (08) :451-452
[24]   High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives [J].
Janjetovic, Z. ;
Brozyna, A. A. ;
Tuckey, R. C. ;
Kim, T-K ;
Nguyen, M. N. ;
Jozwicki, W. ;
Pfeffer, S. R. ;
Pfeffer, L. M. ;
Slominski, A. T. .
BRITISH JOURNAL OF CANCER, 2011, 105 (12) :1874-1884
[25]   The ROR nuclear orphan receptor subfamily: Critical regulators of multiple biological processes [J].
Jetten, AM ;
Kurebayashi, S ;
Ueda, E .
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 69, 2001, 69 :205-247
[26]   Retinoid-related orphan receptors (RORs): roles in cell survival, differentiation and disease [J].
Jetten, AM ;
Ueda, E .
CELL DEATH AND DIFFERENTIATION, 2002, 9 (11) :1167-1171
[27]   POSSIBLE ROLE OF RETINOIC ACID BINDING-PROTEIN IN RETINOID STIMULATION OF EMBRYONAL CARCINOMA CELL-DIFFERENTIATION [J].
JETTEN, AM ;
JETTEN, MER .
NATURE, 1979, 278 (5700) :180-182
[28]  
Jetten AM, 2009, NUCL RECEPT SIGNAL, V7, pe003
[29]  
Jetten AM, 2006, AD DEV BIOL, V16, P313, DOI 10.1016/S1574-3349(06)16010-X
[30]  
Jetten Anton M, 2013, Front Endocrinol (Lausanne), V4, P1, DOI 10.3389/fendo.2013.00001